Follow
Diagnostics
Diagnostics: diagnosis based on information from sources such as findings from a physical examination, interview with the patient or family or both, medical history of the patient and family, and clinical findings as reported by laboratory tests and radiologic studies. Differential diagnosis involves the process of weighing the probability of one disease versus that of other diseases possibly accounting for a patient's illness. The differential diagnosis of rhinitis (a runny nose) includes allergic rhinitis (hayfever), the abuse of nasal decongestants and, of course, the common cold.
APR 05, 2023 | 5:30 AM
C.E. CREDITS
In search of the next generation chromatographic technique for antibody purification, our team has developed an affinity chromatography method using the unconventional nucleotide binding sit...
APR 05, 2023 | 11:00 AM
C.E. CREDITS
Date: April 05, 2023 Time: 11:00am (NZDT) Date: April 04, 2023 Time: 4:00pm (PST), 7:00pm (EST), 1:00pm (CET) Polymerase chain reaction (PCR) technology-based testing method has been widely...
MAR 30, 2023 | 5:00 PM
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...
MAR 30, 2023 | 1:50 PM
C.E. CREDITS
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
MAR 30, 2023 | 1:50 PM
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
MAR 30, 2023 | 1:20 PM
C.E. CREDITS
...
MAR 30, 2023 | 12:05 PM
Dr. Ritterhouse's laboratory has implemented rapid and ultra rapid protocol for NSCLC genomic profiling, based on NGS. This has led to significant shortening of turn around time (TAT) an...
MAR 30, 2023 | 5:10 PM
This talk will highlight key changes to the various guidelines in myeloid and lymphoid testing, commenting on the current and future landscape of biomarkers. The speakers will then share the...
MAR 30, 2023 | 3:15 PM
In her presentation Prof. Staebler will share data generated by new Genomic Assessment Metrics (GIM) software for HRD assessment, and Oncomine Comprehensive Assay Plus. The samples tested we...
MAR 30, 2023 | 1:50 PM
C.E. CREDITS
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms...
